“The men and women I am announcing today will be core members of my national security, foreign policy, and law enforcement team. They are experienced and crisis-tested. They will keep us safe and secure. And, they are leaders who look like America and reflect my core belief that America is back and that we lead not just by the example of our power, but by the power of our example.
I’m honored to introduce these six extraordinary individuals:
Braskem, producer of polyolefins and biopolymers, is meeting the polypropylene raw material needs of medical manufacturing customers for the production of respiratory masks as well as protective medical gear.
“The key concern is that there is no time to wait. We must act now and while countries are starting to make changes to drive a low carbon future, more needs to be done quickly. We need to take more risks and move more quickly. We need to realize the bigger risk is not acting quickly enough”. Jennifer Holmgren talks to Il Bioeconomista. In this exclusive interview, the CEO of LanzaTech gives us her point of view regarding the climate crisis and the ‘carbonsmart’ revolution that the Illinois-based company is leading at global scale.
Gevo Inc., a leading renewable fuels and chemicals manufacturer, signed a Fuel Sales Agreement with Scandinavian Airline System (SAS) to produce and supply sustainable aviation fuel (SAF) for use and distribution in low carbon fuel regions of the United States. With the finalization of this new supply contract, Gevo will supply SAF to SAS from Gevo’s expanded Luverne, Minnesota plant, which is expected to be constructed over the next several years.
According to Thomson Reuters, “corn farmers, ethanol producers, refinery representatives, energy traders and state and local officials from the Midwest all blasted away at the Trump administration’s proposed biofuels plan for next year during a public hearing on Wednesday hosted by the U.S. Environmental Protection Agency (EPA).”
The Office of Science Technology and Policy (OSTP) requests input from all interested parties on the U.S. Bioeconomy. According to OSTP, “the Bioeconomy represents the infrastructure, innovation, products, technology, and data derived from biologically-related processes and science that drive economic growth, promote health, and increase public benefit.”
Cargill is one of the main players of the world bioeconomy. The company founded in 1865 by William Wallace Cargill in Minnesota, USA, has today more than 155,000 employees worldwide serving food and beverage manufacturers, foodservice companies and retailers with food ingredients as well as food and non-food applications.
In this exclusive interview with Il Bioeconomista, Colleen May, President of Cargill’s Bioindustrial Group, tells us what is the bioeconomy from her company’s point of view and what are Cargill’s next steps in the green chemistry.
US companies Phillips 66 and Renewable Energy Group, Inc. joined forces for the construction of a large-scale renewable diesel plant on the U.S. West Coast. The plant would utilize REG’s proprietary BioSynfining® technology for the production of renewable diesel fuel. Planned feedstocks include a mix of waste fats, oils and greases, including regionally-sourced vegetable oils, animal fats and used cooking oil.
BioAmber Inc. filed a voluntary petition for relief under chapter 11 of the United States Bankruptcy Code and that its two Canadian subsidiaries, BioAmber Sarnia Inc. and BioAmber Canada Inc., filed a Notice of Intention to make a proposal under the Bankruptcy and Insolvency Act (Canada), with a view to strengthening the company’s financial health and solidifying its long-term business prospects.
The U.S. Department of Agriculture (USDA) released a new report on the bioeconomy, “Indicators of the U.S. Biobased Economy”, which measures substantial economic growth, job creation, and household income for the agricultural sector from biofuel and bioenergy production. Moreover, it indicates great potential for additional prosperity from future growth in renewable chemicals and biobased products. BIO, the U.S. Biotechnology Innovation Organization, calculates that the global economic value of the biobased economy – including industrial biotechnology, renewable chemicals and polymers, biofuels, enzymes and biobased materials – is $355.28 billion.